Pharmacological Therapy Determines the Gut Microbiota Modulation by a Pomegranate Extract Nutraceutical in Metabolic Syndrome: A Randomized Clinical Trial

نویسندگان

چکیده

Scope Poly-pharmacological therapy shapes the gut microbiota (GM) in metabolic syndrome (MetS) patients. The effects of polyphenols poly-medicated MetS patients are unknown. Methods and results A randomized, placebo-controlled, double-blinded, crossover trial (n=50) explored whether a pomegranate extract nutraceutical (PE, 320 mg phenolics/day for 1 month) affected by drug therapy. Considering lipid-lowering (LL-), anti-hypertensive (HP-) and(or) anti-diabetic (AD-) treatments: GM (16S rRNA sequencing), short-chain fatty acids, 40 inflammatory-metabolic endotoxemia-related biomarkers, associations between biomarkers with 53 cardiometabolic dysfunctions-related single-nucleotide polymorphisms (SNPs), urolithin metabotypes (UMs) influence evaluated. Representative SNPs-GM after PE include Lactococcus ClostridiumXIVa rs5443-GNB3 (G-protein-?-polypeptide-3) rs7903146-TCF7L2 (transcription-factor-7-like-2) rs1137101-LEPR (leptin-receptor). decreases sICAM-1 LL-patients lipopolysaccharide-binding protein all does not affect other patients’ markers as group or stratifying UMs. After PE, increases AD-, LL-, HP-patients, Bifidobacterium LL- while Clostridium XIVa non-LL- non-HP-patients. Conclusion prebiotic effect depends on medication, mainly HP-treatments. Targeting can complement therapy, but should be considered individually.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Manual therapy in the treatment of carpal tunnel syndrome in diabetic patients: A randomized clinical trial

Background: Generally, conservative interventions including physiotherapy modalities and manual therapy have been recommended in the management of carpal tunnel syndrome (CTS), but this subject has not been studied in diabetic patients with CTS. Therefore the aim of this study was to investigate the effects of manual therapy on diabetic patients with CTS. Methods: Thirty diabetic patients with...

متن کامل

The Effect of Dark Chocolate Consumption on Lipid Profile in Patients with Metabolic Syndrome: A Randomized Clinical Trial

Objective: Patients with metabolic syndrome are prone to cardiovascular disease and diabetes. Regarding the importance of nutritional factors in management of metabolic syndrome, this study was designed to evaluate the effects of dark chocolate consumption on serum lipid profile in patients with metabolic syndrome. Materials and Methods: In this randomized clinical trial, 114 patients with met...

متن کامل

The Effect of Oral L-arginine Supplementation on Blood Pressure in Patients with Metabolic Syndrome: A Randomized Clinical Trial

Objective: Hypertension is a common component of metabolic syndrome (MetS). Some studies showed that L-arginine reduced the blood pressure (BP) .Therefore this study was designed to evaluate the effect of L-arginine supplementation on BP in MetS. Materials and Methods: In this randomized, double-blind, placebo-controlled trials, 60 patients with MetS were randomly divided into two groups: the ...

متن کامل

Saffron supplements modulate serum pro-oxidant-antioxidant balance in patients with metabolic syndrome: A randomized, placebo-controlled clinical trial

Objectives: We have investigated the effect of a saffron supplement, given at a dose of 100 mg/kg, on prooxidant-antioxidant balance (PAB) in individuals with metabolic syndrome. Materials and Methods: A randomized, placebo-controlled trial design was used in 75 subjects with metabolic syndrome who were randomly allocated to one of two study groups: (1) the case group received 100mg/kg saffron ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Molecular Nutrition & Food Research

سال: 2021

ISSN: ['1613-4125', '1613-4133']

DOI: https://doi.org/10.1002/mnfr.202001048